BioCardia (BCDA) Insider Trading & Ownership $2.33 -0.06 (-2.51%) Closing price 04:00 PM EasternExtended Trading$2.33 0.00 (0.00%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioCardia (NASDAQ:BCDA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.00%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$510.10KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$6.51K Get BCDA Insider Trade Alerts Want to know when executives and insiders are buying or selling BioCardia stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCDA Insider Buying and Selling by Quarter BioCardia Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/30/2025Andrew Scott BlankDirectorBuy72,289$2.08$150,361.12 6/30/2025David McclungCFOBuy4,819$2.08$10,023.52 6/30/2025Peter AltmanCEOBuy24,096$2.08$50,119.68 6/30/2025Simon H StertzerDirectorBuy72,289$2.08$150,361.12 5/30/2025Peter AltmanCEOBuy100$2.21$221.00 5/22/2025Peter AltmanCEOBuy700$1.89$1,323.00 5/20/2025Peter AltmanCEOBuy1,600$2.08$3,328.00 5/16/2025Peter AltmanCEOBuy300$2.43$729.00 5/14/2025Peter AltmanCEOBuy100$2.99$299.00 4/23/2025Bill FacteauDirectorBuy13,123$1.91$25,064.93 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/23/2025Peter AltmanCEOBuy26,246$1.91$50,129.86 4/15/2025Peter AltmanCEOBuy100$2.14$214.00 4/10/2025Peter AltmanCEOBuy300$1.99$597.00 4/7/2025Peter AltmanCEOBuy500$1.96$980.00 4/3/2025Peter AltmanCEOBuy1,200$2.24$2,688.00 3/5/2025Simon H StertzerDirectorBuy1,000$2.45$2,450.00 3/3/2025Peter AltmanCEOBuy500$2.11$1,055.00 3/3/2025Simon H StertzerDirectorBuy22,753$2.30$52,331.90 2/7/2025Peter AltmanCEOBuy600$2.48$1,488.00 1/29/2025Peter AltmanCEOBuy500$2.40$1,200.00 12/23/2024Peter AltmanCEOBuy1,000$2.06$2,060.00 12/20/2024Edward M GillisSVPSell3,257$2.00$6,514.00 12/5/2024Peter AltmanCEOBuy250$2.22$555.00 11/15/2024Peter AltmanCEOBuy1,350$1.87$2,524.50 (Data available from 1/1/2013 forward) BCDA Insider Trading Activity - Frequently Asked Questions Who is on BioCardia's Insider Roster? The list of insiders at BioCardia includes Andrew Scott Blank, Bill Facteau, David Mcclung, Edward M Gillis, Peter Altman, Phillip Md Et Al Frost, and Simon H Stertzer. Learn more on insiders at BCDA. What percentage of BioCardia stock is owned by insiders? 20.00% of BioCardia stock is owned by insiders. Learn more on BCDA's insider holdings. Which BioCardia insiders have been buying company stock? The following insiders have purchased BCDA shares in the last 24 months: Andrew Scott Blank ($150,361.12), Bill Facteau ($25,064.93), David Mcclung ($10,023.52), Peter Altman ($178,726.04), and Simon H Stertzer ($205,143.02). How much insider buying is happening at BioCardia? Insiders have purchased a total of 255,638 BCDA shares in the last 24 months for a total of $569,318.63 bought. Which BioCardia insiders have been selling company stock? The following insiders have sold BCDA shares in the last 24 months: Edward M Gillis ($6,514.00), and Phillip Md Et Al Frost ($55,811.85). How much insider selling is happening at BioCardia? Insiders have sold a total of 11,910 BioCardia shares in the last 24 months for a total of $62,325.85 sold. BioCardia Key ExecutivesDr. Peter A. Altman Ph.D. (Age 57)CEO, President & Director Compensation: $515.51kMr. David McClung (Age 61)Chief Financial Officer Compensation: $370.86k1 recent tradesMr. Edward M. Gillis (Age 62)Senior Vice President of Devices Compensation: $263.1k More Insider Trading Tools from MarketBeat Related Companies XCUR Insider Trades ACRV Insider Trades PEPG Insider Trades STTK Insider Trades ARTV Insider Trades EGRX Insider Trades ITRM Insider Trades ELYM Insider Trades KPTI Insider Trades AKTX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:BCDA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.